• DOI:10.1016/S1474-4422(03)00531-3
Corpus ID: 38149776

Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

@article{Sen2003TripleHTI,
  title={Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage},
  author={J. Sen and A. Belli and H. Albon and Laleh Morgan and N. Kitchen},
  journal={The Lancet Neurology},
  year={2003},
  volume={2},
  pages={614-621}
}

J. Sen, A. Belli, +2 authors N. Kitchen

Published 2003

Medicine

The Lancet Neurology

Cerebral vasospasm is a recognised but poorly understood complication for many patients who have aneurysmal subarachnoid haemorrhage and can lead to delayed ischaemic neurological deficit (stroke). Morbidity and mortality rates for vasospasm are high despite improvements in management. Since the middle of the 1970s, much has been written about the treatment of cerebral vasospasm. Hypervolaemia, hypertension, and haemodilution (triple-H) therapy in an intensive-care setting has been shown in… CONTINUE READING

View on Elsevier

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed